epocrates logo
epocrates logo
epocrates logo
  • 0

Interaction Check

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

  • remove Myrbetriq
    mirabegron
  • remove Previfem
    norgestimate/ ethinyl estradiol
  • remove Stahist AD
    chlorcyclizine/ pseudoephedrine

multicheck MultiCheck Results - 4 Interactions

Smiley face Smiley face

Monitor/Modify Tx

Smiley face Smiley face Myrbetriq (mirabegron) + Previfem (norgestimate/ ethinyl estradiol)

Monitor/Modify Tx


mirabegron + ethinyl estradiol (contraceptive)

monitor BP: combo may incr. risk of HTN (additive effects)

Smiley face Smiley face Myrbetriq (mirabegron) + Stahist AD (chlorcyclizine/ pseudoephedrine)

Monitor/Modify Tx


mirabegron + pseudoephedrine

monitor BP: combo may incr. risk of HTN (additive effects)

Caution Advised


mirabegron + chlorcyclizine

caution advised: combo may incr. risk of urinary retention (additive effects)

Smiley face Smiley face Previfem (norgestimate/ ethinyl estradiol) + Stahist AD (chlorcyclizine/ pseudoephedrine)

Monitor/Modify Tx


ethinyl estradiol (contraceptive) + pseudoephedrine

monitor BP: combo may incr. risk of HTN (additive effects)

Additional Considerations

Smiley face Smiley face pseudoephedrine in Stahist AD

add MAO inhibitor to Interaction Check if recent (14 days) use

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback Cookie Preferences
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information